| Metric | Q3 2021 | Q2 2021 | Q3 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $78M | — | — | — | — |
| Op. Income | $50M | — | — | — | — |
| Gross Margin | 76.6% | — | — | — | — |
| Net Margin | 54.1% | — | — | — | — |
| EPS (Diluted) | $0.72 | — | — | — | — |
| Free Cash Flow | $351M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $78M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $60M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $10M |
| Operating Expenses | $10M |
| Cost & Expenses | $29M |
| OPERATING INCOME | $50M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $46M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $3M |
| Other Adjustments | $0 |
| NET INCOME | $42M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $42M |
| D&A | $454.0K |
| EBIT | $49M |
| EBITDA | $49M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $78M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $60M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $10M |
| Operating Expenses | $10M |
| Cost & Expenses | $29M |
| OPERATING INCOME | $50M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $46M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $3M |
| Other Adjustments | $0 |
| NET INCOME | $42M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $42M |
| D&A | $454.0K |
| EBIT | $49M |
| EBITDA | $49M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $42M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$6M |
| Change in Working Capital | $314M |
| OPERATING CASH FLOW | $352M |
| Capital Expenditure | -$943.0K |
| Acquisitions (Net) | -$44.0K |
| Purchases of Investments | $42M |
| Sales/Maturities of Investments | $9M |
| Other Investing Activities | $76M |
| NET CASH FROM INVESTING | $127M |
| Net Debt Issuance | -$70M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$70M |
| FREE CASH FLOW | $351M |
| Net Change in Cash | $282M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $625M |
| Short-Term Investments | $345M |
| Net Receivables | $71M |
| Inventory | $0 |
| Other Current Assets | $368M |
| TOTAL CURRENT ASSETS | $1.4B |
| PP&E (Net) | $32M |
| Goodwill | $6M |
| Intangible Assets | $10M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $16M |
| TOTAL NON-CURRENT ASSETS | $65M |
| TOTAL ASSETS | $1.5B |
| Account Payables | $19M |
| Short-Term Debt | $144M |
| Deferred Revenue | $967M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $1.1B |
| Long-Term Debt | $72M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $4M |
| Other Non-Current Liabilities | $24M |
| TOTAL NON-CURRENT LIABILITIES | $113M |
| TOTAL LIABILITIES | $1.2B |
| Common Stock | $58.0K |
| Additional Paid-In Capital | $105M |
| Retained Earnings | $156M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$33M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $228M |
| Minority Interest | -$2M |
| TOTAL EQUITY | $226M |
| TOTAL LIABILITIES & EQUITY | $1.5B |
| Total Debt | $230M |
| Net Debt | -$394M |
